Literature DB >> 27604928

Boom in unproven cell therapies intensifies regulatory debate.

Heidi Ledford.   

Abstract

Mesh：

Year:  2016        PMID： 27604928     DOI： 10.1038/537148a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Regulation: Rewriting the regenerative rulebook.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

2.  Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.

Authors:  Michael G Liska; Marci G Crowley; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2017-01-26       Impact factor: 6.829

Review 3.  Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation.

Authors:  Pablo Bora; Anish S Majumdar
Journal:  Stem Cell Res Ther       Date:  2017-06-15       Impact factor: 6.832
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.